Results 151 to 160 of about 112,758 (355)

The relationship between Human Papillomavirus and Epstein-Barr virus infections with breast cancer of Iranian patients [PDF]

, 2013
Zahra Tahmasebi Fard
openalex   +1 more source

Beyond PD‐1: Mechanisms of Resistance to Checkpoint Blockade in Classical Hodgkin Lymphoma and Next‐Generation Immune Strategies

European Journal of Haematology, EarlyView.
ABSTRACT PD‐1 inhibitors have reshaped the treatment landscape of classical Hodgkin lymphoma, yet a substantial proportion of patients exhibit primary or acquired resistance driven by tumor‐intrinsic alterations, immunosuppressive microenvironmental signals, metabolic constraints, and EBV‐mediated modulation.
Santino Caserta, Enrica Antonia Martino, Mamdouh Skafi, Maria Eugenia Alvaro, Antonella Bruzzese, Nicola Amodio, Eugenio Lucia, Virginia Olivito, Caterina Labanca, Francesco Mendicino, Ernesto Vigna, Fortunato Morabito, Massimo Gentile   +12 more
wiley   +1 more source

Laparoscopic Splenectomy for Inflammatory Pseudotumor‐Like Follicular Dendritic Cell Sarcoma: A RareEpstein–Barr Virus‐Associated Splenic Tumor

The Kaohsiung Journal of Medical Sciences, EarlyView.
Hsin‐Yi Lin, Po‐Hsuan Wu, Hui‐Gin Chiu, Jia‐Yu Chen   +3 more
wiley   +1 more source

Newly identified properties of known pharmaceuticals and myxobacterial small molecules revealed by screening for autophagy modulators

The FEBS Journal, EarlyView.
Autophagy is a cellular degradation process involved in, for example, immune responses to pathogens and neurodegeneration. To identify modulators of autophagy, we developed a microscopy‐based screening assay and identified previously unknown autophagy‐modulating activities in known drugs and natural products from myxobacteria and fungi.
Janine Fichtner, Yan Yan Beer, H. G. Mauricio Ramm, Sabrina Mühlen, Frank Surup, Jennifer Herrmann, Toni Luise Meister, Stephanie Pfaender, Ursula Bilitewski, Mark Brönstrup, Rolf Müller, Manfred Wirth, Eeva‐Liisa Eskelinen, Ingo Schmitz   +13 more
wiley   +1 more source

Weekly long-term intravenous immunoglobulin for refractory parvovirus B19 and Epstein-Barr virus-induced immune thrombocytopenic purpura

The Turkish Journal of Pediatrics, 2008
In pediatric acute immune thrombocytopenic purpura (ITP) cases, it is usually possible to determine an underlying pathology; among them, viral infections are the leading causative agents.
Betül Tavil, Sule Unal, Selin Aytaç-Elmas, Sevgi Yetgin   +3 more
doaj  

In-cell infection: a novel pathway for Epstein-Barr virus infection mediated by cell-in-cell structures [PDF]

, 2015
Chao Ni, Yuhui Chen, Mu‐Sheng Zeng, Rongjuan Pei, Yong Du, Lin‐Quan Tang, Mengyi Wang, Yazhuo Hu, Hanyu Zhu, Meifang He, Xiawei Wei, Shan Wang, Xiangkai Ning, Manna Wang, Jufang Wang, Li Ma, Xinwen Chen, Qiang Sun, Hong Tang, Ying Wang, Xiaoning Wang   +20 more
openalex   +1 more source

Appendiceal Crohn's Disease Manifesting as Appendiceal Malignancy: A Case Report and Review of the Literature

The Kaohsiung Journal of Medical Sciences, EarlyView.
Ming‐Jung Meng, Tai‐Di Chen, Puo‐Hsien Le, Chia‐Jung Kuo   +3 more
wiley   +1 more source

Differential regulation of translational stress responses by herpesvirus ubiquitin deconjugases

The FEBS Journal, EarlyView.
Translating viral mRNAs is challenging due to structural features that may slow translation or induce ribosome stalling. The viral ubiquitin deconjugases encoded by human pathogenic herpesviruses regulate the cellular response to ribosomal stress by inhibiting various branches of the Ribosomal Quality Control (RQC) and activating Ribosomal Stress ...
Jiangnan Liu, Noemi Nagy, Carlos Mario Ayala‐Torres, Maria G. Masucci   +3 more
wiley   +1 more source

A 52‐week open‐label extension study to evaluate the safety and efficacy of oral rimegepant for the preventive treatment of migraine

Headache: The Journal of Head and Face Pain, EarlyView.
Abstract Objective To assess the safety, tolerability, and treatment effects of rimegepant 75 mg every other calendar day (EOD) for the preventive treatment of migraine in a 52‐week, open‐label extension (OLE) study. Background Rimegepant is an oral small molecule calcitonin gene–related peptide receptor antagonist approved for the acute treatment of ...
David Kudrow, Robert S. Croop, Alexandra Thiry, Richard B. Lipton   +3 more
wiley   +1 more source

Accelerated Suppression of Primary Epstein-Barr Virus Infection in HIV-Infected Infants Initiating Lopinavir/Ritonavir-Based Versus Nevirapine-Based Combination Antiretroviral Therapy [PDF]

, 2014
Jennifer A. Slyker, Corey Casper, Kenneth Tapia, Barbra A. Richardson, Lisa Bunts, Meei‐Li Huang, Dalton Wamalwa, Sarah Benki‐Nugent, Grace John‐Stewart   +8 more
openalex   +1 more source